3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
2
Plasmacytoma
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphedema
1
Fallopian Tube Neoplasms
1
Disease Progression
1
Breast Neoplasms
1
Arsenic Poisoning
1
Interventions
Carboplatin
75
Paclitaxel
68
Bevacizumab
44
Taxes
22
Cyclophosphamide
21
pembrolizumab
19
Gemcitabine
19
Cisplatin
18
Topotecan
17
Hyperthermic Intraperitoneal Chemotherapy
14
olaparib
13
liposomal doxorubicin
13
Immunoglobulin G
13
Disulfides
13
Specimen Handling
11
Drug Therapy
11
niraparib
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
sargramostim
7
Surveys and Questionnaires
7
Doxorubicin
7
Docetaxel
7
durvalumab
6
Platinum
6
Nivolumab
6
Letrozole
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fallopian Tube Neoplasms
×
Sodium Selenite
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled